Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus
Clinical trial NCT02044848 · TERMINATED
Trial details
- NCT number
- NCT02044848
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.